MILD COGNITIVE IMPAIRMENT TREATMENT SECRETS

Prescribing data for lecanemab features a boxed warning about probable risks linked to ARIA. Correct use recommendations focus on methods to reduce ARIA possibility, as does AAN direction.PET scans. These scans can demonstrate designs of brain activity. They can identify whether amyloid or tau protein, hallmarks of Alzheimer's disorder, are deposit